TW202333732A - 呼吸道刺激劑之非經腸調配物 - Google Patents

呼吸道刺激劑之非經腸調配物 Download PDF

Info

Publication number
TW202333732A
TW202333732A TW111150221A TW111150221A TW202333732A TW 202333732 A TW202333732 A TW 202333732A TW 111150221 A TW111150221 A TW 111150221A TW 111150221 A TW111150221 A TW 111150221A TW 202333732 A TW202333732 A TW 202333732A
Authority
TW
Taiwan
Prior art keywords
formulation
substituted
compound
acid
parenteral formulation
Prior art date
Application number
TW111150221A
Other languages
English (en)
Chinese (zh)
Inventor
喬瑟夫 Ｖ 伯格利兹
法蘭克 黛安娜
陳佳翌
狄翁 Ｅ 杜德
以薩 阿吉曼
Original Assignee
美商安納萊爾治療公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商安納萊爾治療公司 filed Critical 美商安納萊爾治療公司
Publication of TW202333732A publication Critical patent/TW202333732A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
TW111150221A 2021-12-27 2022-12-27 呼吸道刺激劑之非經腸調配物 TW202333732A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202163293985P 2021-12-27 2021-12-27
US63/293,985 2021-12-27
US202263313472P 2022-02-24 2022-02-24
US63/313,472 2022-02-24

Publications (1)

Publication Number Publication Date
TW202333732A true TW202333732A (zh) 2023-09-01

Family

ID=86992921

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111150221A TW202333732A (zh) 2021-12-27 2022-12-27 呼吸道刺激劑之非經腸調配物

Country Status (9)

Country Link
US (1) US20230210857A1 (enExample)
EP (1) EP4456900A4 (enExample)
JP (1) JP2025501169A (enExample)
KR (1) KR20240150426A (enExample)
AU (1) AU2022426492A1 (enExample)
CA (1) CA3242509A1 (enExample)
MX (1) MX2024008162A (enExample)
TW (1) TW202333732A (enExample)
WO (1) WO2023129502A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4543455A4 (en) * 2022-06-24 2026-06-03 Enalare Therapeutics Inc METHODS OF TREATMENT FOR NEUROLOGICAL VENTILATORY FAILURE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69729880T3 (de) * 1996-12-24 2012-05-10 Biogen Idec Ma Inc. Stabile flüssige interferon-zubereitungen
SG10201601507YA (en) * 2010-11-29 2016-04-28 Galleon Pharmaceuticals Inc Novel compounds as respiratory stimulants for treatment of breathing control disorders or diseases
US20120295911A1 (en) * 2010-11-29 2012-11-22 Galleon Pharmaceuticals, Inc. Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases
AU2012250050B2 (en) * 2011-04-28 2017-04-06 Platform Brightworks Two, Ltd. Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
BR112015011213A2 (pt) * 2012-11-15 2017-08-29 Galleon Pharmaceuticals Inc Composto, composição farmacêutica, método de prevenção ou tratamento de um distúrbio ou doença de controle respiratório em um indivíduo, método de prevenção de desestabilização ou de estabilização do ritmo respiratório em um indivíduo, método de preparação de o,n-dimetil-n-[4-(n-propilamina)-6-(prop-2-inilamina)-[1,3,5]triazin-2-il]-hidroxilamina, e composição.
GB201502412D0 (en) * 2015-02-13 2015-04-01 Canbex Therapeutics Ltd Therapeutic use

Also Published As

Publication number Publication date
EP4456900A1 (en) 2024-11-06
WO2023129502A1 (en) 2023-07-06
KR20240150426A (ko) 2024-10-15
US20230210857A1 (en) 2023-07-06
MX2024008162A (es) 2024-09-17
JP2025501169A (ja) 2025-01-17
EP4456900A4 (en) 2025-12-24
CA3242509A1 (en) 2023-07-06
AU2022426492A1 (en) 2024-07-18

Similar Documents

Publication Publication Date Title
US20230310440A1 (en) Respiratory stimulant nasal formulations
US20250114370A1 (en) Methods and compositions for treating drug overdose
KR102345271B1 (ko) 미용 조성물의 안정화
JP2024517463A (ja) ニコチンアミドアデニンジヌクレオチド（ｎａｄ）組成物、それらの製造方法、及びそれらの使用方法
US20250032496A1 (en) Methods of treating respiratory depression modulated by a non-opioid agent
CN116075310A (zh) 局部用维生素c组合物
US20230210857A1 (en) Respiratory stimulant parenteral formulations
JP2023041793A (ja) 外用組成物
US20240238303A1 (en) Large-conductance potassium channel modulators, compositions thereof, methods of manufacturing thereof, and methods of use thereof
RU2743039C2 (ru) Препарат для кожи местного применения против морщин
US20230414624A1 (en) Methods of treating neurological ventilatory insufficiency
CN118829433A (zh) 呼吸刺激剂肠胃外制剂
CN101128193B (zh) 抗自由基剂
TW202529771A (zh) 用於治療藥物過量的方法及組合物
HK40094063A (en) Topical vitamin c composition